MediciNova Presents Examine Replace and Interim Evaluation of Section 2/3 Scientific Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Scientific Trial) on the thirty fifth Worldwide Symposium on ALS/MND By Investing.com
LA JOLLA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- MediciNova (NASDAQ:), Inc.,…
Donaldson Firm to Current on the Gabelli Funds forty eighth Annual Automotive Aftermarket Symposium By Investing.com
MINNEAPOLIS--(BUSINESS WIRE)--Donaldson Firm, Inc. (NYSE: DCI), a number one worldwide supplier of…
Minerals Applied sciences Broadcasts Participation in Gabelli Funds 2nd Annual PFAS Symposium By Investing.com
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Minerals Applied sciences Inc…
